P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Weisel, Katja, D’souza, Anita, Hurd, David, Voorhees, Peter, Teipel, Raphael, Chung, Alfred, Rodriguez, Cesar, Tuchman, Sacha, Korde, Neha, Safah, Hana, Bueno, Orlando, Feng, Zhongling, Rosenberg, Tanya, Kumar Pothacamury, Rajvineeth, Ross, Jeremy, Lee, Shane, Jin, Ziyi, Talati, Chetasi, Kumar, Shaji, Vij, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431066/
http://dx.doi.org/10.1097/01.HS9.0000970352.00363.07
Descripción
Sumario:

Ejemplares similares